John D Scandling Jr. MD
Professor, Medicine - Nephrology, Stanford University Medical Center
Join to View Full Profile
300 Pasteur DrPalo Alto, CA 94305
Phone+1 650-725-9891
Dr. Scandling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Rochester Medical CenterFellowship, Nephrology, 1981 - 1982
West Virginia UniversityResidency, Internal Medicine, 1978 - 1981
Virginia Commonwealth University School of MedicineClass of 1978
Certifications & Licensure
CA State Medical License 1989 - 2026
NV State Medical License 2019 - 2025
VA State Medical License 1984 - 2002
NY State Medical License 1981 - 1997
WV State Medical License 1979 - 1995
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2014, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2014, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) Start of enrollment: 2005 Jun 01
- Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs Start of enrollment: 2004 Jul 01
- Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs. Start of enrollment: 2010 Jul 14
Publications & Presentations
PubMed
- Corrigendum: Quality of life improvements and clinical assessments in kidney transplant recipients undergoing pegloticase treatment for uncontrolled gout: findings of ...Abdul Abdellatif, Lin Zhao, Katie Obermeyer, Zana Vranic, Brad A Marder
Frontiers in Immunology. 2025-01-01 - 3 citationsQuality of life improvements and clinical assessments in kidney transplant recipients undergoing pegloticase treatment for uncontrolled gout: findings of the phase 4 P...Abdul Abdellatif, Lin Zhao, Katie Obermeyer, Zana Vranic, Brad A Marder
Frontiers in Immunology. 2025-01-01 - 1 citationsThe Medical Costs of Determining Eligibility and Waiting for a Kidney Transplantation.Kunyao Xu, Avi Dor, Suman Mohanty, Jialin Han, Gomathy Parvathinathan
Medical Care. 2024-08-01
Journal Articles
- Review Macrochimerism and Clinical Transplant ToleranceSamuel Strober, Stephan Busque, Edgar Engleman, Robert Lowsky, John D Scandling, Judith Shizuru, ScienceDirect
Press Mentions
Stanford Team Prevents Kidney Transplant Rejection Without DrugsApril 24th, 2002
Grant Support
- Cyclosporine &Neoral In Post Renal Allograft RecipientsNational Center For Research Resources1999–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
